68 related articles for article (PubMed ID: 2573444)
1. Clinical evaluation of a benzofuroquinolizine alpha 2-adrenoceptor antagonist.
Gertz BJ; Vlasses PH; Rocci ML; Coker LD; Williams V; Bjornsson TD; Jones KH
Clin Pharmacol Ther; 1989 Nov; 46(5):566-75. PubMed ID: 2573444
[TBL] [Abstract][Full Text] [Related]
2. Assessment of MK-912, an alpha 2-adrenoceptor antagonist, with use of intravenous clonidine.
Warren JB; Dollery CT; Fuller RW; Williams VC; Gertz BJ
Clin Pharmacol Ther; 1989 Jul; 46(1):103-9. PubMed ID: 2568210
[TBL] [Abstract][Full Text] [Related]
3. Assessment of MK-467, a peripheral alpha 2-adrenergic receptor antagonist, with intravenous clonidine.
Warren JB; Dollery CT; Sciberras D; Goldberg MR
Clin Pharmacol Ther; 1991 Jul; 50(1):71-7. PubMed ID: 1677320
[TBL] [Abstract][Full Text] [Related]
4. Effect of an oral alpha 2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitus.
Ortiz-Alonso FJ; Herman WH; Gertz BJ; Williams VC; Smith MJ; Halter JB
Metabolism; 1991 Nov; 40(11):1160-7. PubMed ID: 1682787
[TBL] [Abstract][Full Text] [Related]
5. The effects of a peripherally selective alpha 2-adrenoceptor antagonist, MK-467, on the metabolic and cardiovascular response to exercise in healthy man.
Sciberras DG; Reed JW; Elliott C; Blain PG; Goldberg MR
Br J Clin Pharmacol; 1994 Jan; 37(1):39-44. PubMed ID: 7908531
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers.
Karhuvaara S; Kallio A; Scheinin M; Anttila M; Salonen JS; Scheinin H
Br J Clin Pharmacol; 1990 Jul; 30(1):97-106. PubMed ID: 1975199
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of Glibenclamide Hypoglycaemia in Mice by MK-467, a Peripherally Acting Alpha2-Adrenoceptor Antagonist.
Ruohonen ST; Ranta-Panula V; Bastman S; Chrusciel P; Scheinin M; Streng T
Basic Clin Pharmacol Toxicol; 2015 Dec; 117(6):392-8. PubMed ID: 26132275
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.
Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ
Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663
[TBL] [Abstract][Full Text] [Related]
9. A preliminary, clinical pharmacological assessment of L-659,066, a novel alpha 2-adrenoceptor antagonist.
Schafers RF; Elliott HL; Howie CA; Reid JL
Br J Clin Pharmacol; 1992 Dec; 34(6):521-6. PubMed ID: 1362887
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the effect of mirodenafil on the hemodynamics of healthy male Korean volunteers administered tamsulosin: a randomized, double-blind, placebo-controlled, 2-period crossover study.
Gu N; Kim J; Lim KS; Shin KH; Kim TE; Lee B; Shin SG; Jang IJ; Yu KS
Clin Ther; 2012 Sep; 34(9):1929-39. PubMed ID: 22921287
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent alpha 1-adrenoceptor antagonist activity of the anti-arrhythmic drug, abanoquil (UK-52,046), without reduction in blood pressure in man.
Tham TC; Guy S; Shanks RG; Harron DW
Br J Clin Pharmacol; 1992 Apr; 33(4):405-9. PubMed ID: 1349492
[TBL] [Abstract][Full Text] [Related]
12. Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: I. Effects on blood pressure, heart rate and pressor responsiveness in normotensive subjects.
Schafers RF; Elliott HL; Howie CA; Reid JL
Br J Clin Pharmacol; 1991 Nov; 32(5):599-604. PubMed ID: 1683249
[TBL] [Abstract][Full Text] [Related]
13. Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects.
Guhan AR; Cooper S; Oborne J; Lewis S; Bennett J; Tattersfield AE
Thorax; 2000 Aug; 55(8):650-6. PubMed ID: 10899240
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of the effects of clonidine by the alpha 2-adrenoceptor antagonist, fluparoxan.
Johnson MA; Blackwell CP; Smith J
Br J Clin Pharmacol; 1995 May; 39(5):477-83. PubMed ID: 7669482
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
Pandhi P; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):297-300. PubMed ID: 2887519
[TBL] [Abstract][Full Text] [Related]
16. A dual PPAR alpha/gamma agonist increases adiponectin and improves plasma lipid profiles in healthy subjects.
Decochez K; Rippley RK; Miller JL; De Smet M; Yan KX; Matthijs Z; Riffel KA; Song H; Zhu H; Maynor HO; Tanaka W; Johnson-Levonas AO; Davies MJ; Gottesdiener KM; Keymeulen B; Wagner JA
Drugs R D; 2006; 7(2):99-110. PubMed ID: 16542056
[TBL] [Abstract][Full Text] [Related]
17. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects.
Weber C; Schmitt R; Birnboeck H; Hopfgartner G; van Marle SP; Peeters PA; Jonkman JH; Jones CR
Clin Pharmacol Ther; 1996 Aug; 60(2):124-37. PubMed ID: 8823230
[TBL] [Abstract][Full Text] [Related]
19. Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjects.
Schafers RF; Elliott HL; Meredith PA; Miller SH; Reid JL
Br J Clin Pharmacol; 1991 Nov; 32(5):605-10. PubMed ID: 1683250
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses.
Herman GA; Stevens C; Van Dyck K; Bergman A; Yi B; De Smet M; Snyder K; Hilliard D; Tanen M; Tanaka W; Wang AQ; Zeng W; Musson D; Winchell G; Davies MJ; Ramael S; Gottesdiener KM; Wagner JA
Clin Pharmacol Ther; 2005 Dec; 78(6):675-88. PubMed ID: 16338283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
